Article Information
History
- June 27, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Toshiya Mitsunaga1,2,*,
- Yuhei Ohtaki2,
- Yutaka Seki1,3,4,
- Masakata Yoshioka4,
- Hiroshi Mori5,
- Midori Suzuka6,
- Syunsuke Mashiko2,
- Satoshi Takeda2 and
- Kunihiro Mashiko1
- 1Department of Emergency Medicine, Association of EISEIKAI Medical and Healthcare Corporation Minamitama Hospital, Tokyo, Japan
- 2Department of Emergency Medicine, Jikei University School of Medicine, Tokyo, Japan
- 3Department of Cardiology, Association of EISEIKAI Medical and Healthcare Corporation Minamitama Hospital, Tokyo, Japan
- 4Department of Internal Medicine, Association of EISEIKAI Medical and Healthcare Corporation Minamitama Hospital, Tokyo, Japan
- 5Department of Medical Engineering, Association of EISEIKAI Medical and Healthcare Corporation Minamitama Hospital, Tokyo, Japan
- 6Department of Pharmacy, Association of EISEIKAI Medical and Healthcare Corporation Minamitama Hospital, Tokyo, Japan
- ↵*Corresponding Author: Toshiya Mitsunaga1,2, 3-10-1, Sanda-machi, Hachioji-city, Tokyo, 1930832, Japan, Email address: toshiya.m{at}jikei.ac.jp
Posted June 27, 2021.
The evaluation of factors affecting antibody response after administration of the BNT162b2 vaccine: A prospective study in Japan
